The P.R.OS.T.A.T.E Nomogram for the Preoperative Prediction of Clinical Efficacy of Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia Patients

References

• McNeal J. Pathology of benign prostatic hyperplasia. Insight into etiology. Urol Clin North Am. 1990;17(3):477–486. doi:10.1016/S0094-0143(21)00961-7
   PubMed Web of Science ®Google Scholar
• Bortnick EM, Simma-Chiang V, Kaplan SA. Long-term consequences of medical therapy for benign prostatic hyperplasia. Rev Urol. 2019;21(4):154–157.
   PubMedGoogle Scholar
• Kim SJ, Al Hussein Alawamlh O, Chughtai B, et al. Lower urinary tract symptoms following transurethral resection of prostate. Curr Urol Rep. 2018;19(10):85–91. doi:10.1007/s11934-018-0838-4
   PubMed Web of Science ®Google Scholar
• Zhao Y, Liu W, Guralnick M, et al. Predictors of short-term overactive bladder symptom improvement after transurethral resection of prostate in men with benign prostatic obstruction. Int J Urol. 2014;21(10):1035–1040. doi:10.1111/iju.12482
   PubMed Web of Science ®Google Scholar
• Stoddard MD, Zheng X, Mao J, et al. Safety and efficacy of outpatient surgical procedures for the treatment of benign prostatic enlargement in New York State and California (2005–2016). J Urol. 2021;205(3):848–854. doi:10.1097/JU.0000000000001401
   PubMed Web of Science ®Google Scholar
• De Nunzio C, Lombardo R, Nacchia A, et al. Young Academic Urologists’ benign prostatic obstruction nomogram predicts clinical outcome in patients treated with transurethral resection of prostate: an Italian cohort study. Minerva Urol Nefrol. 2018;70(2):211–217. doi:10.23736/S0393-2249.17.03008-9
   PubMed Web of Science ®Google Scholar
• Chen X, Man Q, Wei X, et al. Predictive value of preoperative comprehensive evaluation on the efficacy of HoLEP. Transl Androl Urol. 2020;9(4):1603–1610. doi:10.21037/tau-20-504
   PubMed Web of Science ®Google Scholar
• Kwon JK, Han JH, Choi HC, et al. Clinical significance of peripheral zone thickness in men with lower urinary tract symptoms/benign prostatic hyperplasia. BJU Int. 2016;117(2):316–322. doi:10.1111/bju.13130
   PubMed Web of Science ®Google Scholar
• Tian Y, Liu HM, Yang B, et al. Prostatic anatomical parameters correlate with clinical characteristics suggestive of benign prostatic hyperplasia. Asian J Androl. 2021;23(1):64–68. doi:10.4103/aja.aja_47_20
   PubMed Web of Science ®Google Scholar
• Franco G, De Nunzio C, Leonardo C, et al. Ultrasound assessment of intravesical prostatic protrusion and detrusor wall thickness–new standards for noninvasive bladder outlet obstruction diagnosis? J Urol. 2010;183(6):2270–2274. doi:10.1016/j.juro.2010.02.019
   PubMed Web of Science ®Google Scholar
• Aso Y, Homma Y. Clinical research criteria: response criteria for evaluating efficacy of treatments for benign prostatic hypertrophy. Br J Urol. 1995;76(Suppl 1):69–73.
   PubMedGoogle Scholar
• Milonas D, Saferis V, Jievaltas M. Transition zone index and bothersomeness of voiding symptoms as predictors of early unfavorable outcomes after transurethral resection of prostate. Urol Int. 2008;81(4):421–426. doi:10.1159/000167840
   PubMed Web of Science ®Google Scholar
• Antunes AA, Iscaife A, Reis ST, et al. Can we predict which patients will experience resolution of detrusor overactivity after transurethral resection of the prostate? J Urol. 2015;193(6):2028–2032. doi:10.1016/j.juro.2014.12.095
   PubMed Web of Science ®Google Scholar
• Seki N, Yuki K, Takei M, et al. Analysis of the prognostic factors for overactive bladder symptoms following surgical treatment in patients with benign prostatic obstruction. Neurourol Urodyn. 2009;28(3):197–201. doi:10.1002/nau.20619
   PubMed Web of Science ®Google Scholar
• Choi H, Kim JH, Shim JS, et al. Prediction of persistent storage symptoms after transurethral resection of the prostate in patients with benign prostatic enlargement. Urol Int. 2014;93(4):425–430. doi:10.1159/000357626
   PubMed Web of Science ®Google Scholar
• Smith PP, DeAngelis A, Kuchel GA. Detrusor expulsive strength is preserved, but responsiveness to bladder filling and urinary sensitivity is diminished in the aging mouse. Am J Physiol Regul Integr Comp Physiol. 2012;302(5):R577–R586. doi:10.1152/ajpregu.00508.2011
   PubMed Web of Science ®Google Scholar
• Rhodes T, Girman CJ, Jacobsen SJ, et al. Longitudinal prostate growth rates during 5 years in randomly selected community men 40 to 79 years old. J Urol. 1999;161(4):1174–1179. doi:10.1097/00005392-199904000-00033
   PubMed Web of Science ®Google Scholar
• Eckhardt MD, van Venrooij GE, Boon TA. Symptoms and quality of life versus age, prostate volume, and urodynamic parameters in 565 strictly selected men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Urology. 2001;57(4):695–700. doi:10.1016/S0090-4295(00)01101-8
   PubMed Web of Science ®Google Scholar
• Simon RM, Howard LE, Moreira DM, et al. Does prostate size predict the development of incident lower urinary tract symptoms in men with mild to no current symptoms? Results from the REDUCE trial. Eur Urol. 2016;69(5):885–891. doi:10.1016/j.eururo.2015.12.002
   PubMed Web of Science ®Google Scholar
• St SJ, Jacobson DJ, Girman CJ, et al. Correlations between longitudinal changes in transitional zone volume and measures of benign prostatic hyperplasia in a population-based cohort. Eur Urol. 2006;50(1):105–111. doi:10.1016/j.eururo.2006.01.013
   PubMed Web of Science ®Google Scholar
• Matsugasumi T, Fujihara A, Ushijima S, et al. Morphometric analysis of prostate zonal anatomy using magnetic resonance imaging: impact on age-related changes in patients in Japan and the USA. BJU Int. 2017;120(4):497–504. doi:10.1111/bju.13823
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Masumori N, Itoh N, et al. Is the short-term outcome of transurethral resection of the prostate affected by preoperative degree of bladder outlet obstruction, status of detrusor contractility or detrusor overactivity? Int J Urol. 2006;13(11):1398–1404. doi:10.1111/j.1442-2042.2006.01589.x
   PubMed Web of Science ®Google Scholar
• Matsukawa Y, Ishida S, Majima T, et al. Intravesical prostatic protrusion can predict therapeutic response to silodosin in male patients with lower urinary tract symptoms. Int J Urol. 2017;24(6):454–459. doi:10.1111/iju.13333
   PubMed Web of Science ®Google Scholar
• Lin YT, Amouyal G, Thiounn N, et al. Intra-vesical Prostatic Protrusion (IPP) can be reduced by prostatic artery embolization. Cardiovasc Interv Radiol. 2016;39(5):690–695. doi:10.1007/s00270-015-1235-8
   PubMed Web of Science ®Google Scholar
• Kuo HC. Clinical prostate score for diagnosis of bladder outlet obstruction by prostate measurements and uroflowmetry. Urology. 1999;54(1):90–96. doi:10.1016/S0090-4295(99)00092-8
   PubMed Web of Science ®Google Scholar
• De Nunzio C, Lombardo R, Cicione A, et al. The role of bladder wall thickness in the evaluation of detrusor underactivity: development of a clinical nomogram. Neurourol Urodyn. 2020;39(4):1115–1123. doi:10.1002/nau.24327
   PubMed Web of Science ®Google Scholar
• Homma Y, Imajo C, Kawabe K, et al. Response criteria for the therapeutic efficacy of treatment for benign prostatic hyperplasia. Int J Urol. 1995;2(1):33–38. doi:10.1111/j.1442-2042.1995.tb00617.x
   PubMedGoogle Scholar
• Choi J, Ikeguchi EF, Lee SW, et al. Is the higher prevalence of benign prostatic hyperplasia related to lower urinary tract symptoms in Korean men due to a high transition zone index? Eur Urol. 2002;42(1):7–11. doi:10.1007/978-3-642-78185-8_11
   PubMed Web of Science ®Google Scholar
• Marks LS, Roehrborn CG, Wolford E, et al. The effect of dutasteride on the peripheral and transition zones of the prostate and the value of the transition zone index in predicting treatment response. J Urol. 2007;177(4):1408–1413. doi:10.1016/j.juro.2006.11.095
   PubMed Web of Science ®Google Scholar